Edition:
United States

Sol Gel Technologies Ltd (SLGL.OQ)

SLGL.OQ on NASDAQ Stock Exchange Global Market

6.22USD
7 Dec 2018
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$6.22
Open
$6.35
Day's High
$6.45
Day's Low
$6.19
Volume
2,175
Avg. Vol
5,445
52-wk High
$16.47
52-wk Low
$6.00

Summary

Name Age Since Current Position

Alon Seri-Levy

56 Chief Executive Officer, Co-Founder, Director

Gilad Mamlok

49 2017 Chief Financial Officer

Itzik Yosef

41 2016 Vice President - Operations

Ofra Levy-Hacham

51 Vice President - Quality and Regulatory Affairs

Karine Neimann

46 2016 Vice President - Projects and Planning, Chief Chemist

Dov Zamir

64 2016 Vice President - Special Projects

Ofer Toledano

52 2004 Vice President, Research & Development

Itai Arkin

29 Director

Jerrold Gattegno

65 Director

Ran Gottfried

73 Director

Hani Lerman

45 Director

Yael Baratz

61 Independent Director

Shmuel Ben Zvi

57 Independent Director

Biographies

Name Description

Alon Seri-Levy

Dr. Alon Seri-Levy is Chief Executive Officer, Co-Founder, Director of the Company. He co-founded Sol-Gel and has served as our chief executive officer since our inception in 1997 and as a member of our board of directors until 2014. Prior to founding Sol-Gel, Dr. Seri-Levy established the computer-aided drug design department at Peptor Ltd., an Israeli research and development company that specialized in the development of peptide-based drug products. Dr. Seri-Levy holds a Ph.D. in Chemistry (summa cum laude) from The Hebrew University of Jerusalem, Israel, and conducted his post-doctoral studies at Oxford University, United Kingdom. Dr. Seri-Levy was appointed to our board of directors immediately following the pricing of this offering.

Gilad Mamlok

Mr. Gilad Mamlok is Chief Financial Officer of the Company. From August 2015 to January 2017, Mr. Mamlok served as the chief financial officer for Medigus Ltd., a medical device company dual listed on Nasdaq and the Tel Aviv Stock Exchange, or the TASE. From September 2005 to March 2015, Mr. Mamlok served as senior vice president, global finance and accounting of Given Imaging Ltd., a medical device company dual listed on Nasdaq and TASE, acquired by Covidien plc in February 2014. From January 2002 to September 2005, Mr. Mamlok served as chief financial officer of two other medical device companies. Mr. Mamlok holds a Master’s degree in business economics from Tel-Aviv University and a B.A. in economics (magna cum laude) from Tel-Aviv University, Israel.

Itzik Yosef

Dr. Itzik Yosef is Vice President - Operations of the Company since August 2016. Since joining us in 2010, Dr. Yosef held various positions including as head of operations. Dr. Yosef holds a Ph.D. in chemistry from The Hebrew University of Jerusalem, Israel.

Ofra Levy-Hacham

Dr. Ofra Levy-Hacham is Vice President - Quality and Regulatory Affairs of Sol-Gel Technologies Ltd. She manages Sol-Gel’s quality systems and compliance initiatives. Dr. Levy-Hacham is an experienced specialist in manufacturing control, QA and QC management, drug discovery and regulatory affairs. Before joining Sol-Gel, Dr. Levy-Hacham was VP of CMC at HealOr Ltd., senior positions in the QA of Bio-Technology General and other pharmaceutical companies. Dr. Levy-Hacham received her PhD in Chemistry from the Faculty of Chemistry, Technion Haifa, Israel.

Karine Neimann

Dr. Karine Neimann is Vice President - Projects and Planning, Chief Chemist of the Company since September 2016. Since joining us in 2008, Dr. Neimann held various positions, including as chief chemist and laboratory manager. Dr. Neimann holds a Ph.D. in chemistry from The Hebrew University of Jerusalem, Israel.

Dov Zamir

Dr. Dov Zamir is Vice President - Special Projects of the Company since August 2016. Prior to joining us, Dr. Zamir lead the R&D group in Cima NanoTech Ltd., a private company developing sophisticated nanotechnology based coating formulations from 2007 until 2016. From 2004 to 2007, Dr. Zamir was VP of Pharma and Analytical R&D at Taro Pharmaceutical Industries in Haifa, and for three years prior to that he managed its Analytical R&D lab. Dr. Zamir holds a Ph.D. in organic chemistry from Tel-Aviv University, Israel.

Ofer Toledano

Dr. Ofer Toledano is Vice President of Research and Development of Sol-GelTechnologies Ltd since 2004. Prior to joining Sol-Gel, Dr. Toledano served as manager of the formulation department at ADAMA Agricultural Solutions Ltd. (formerly known as Makhteshim Agan Industries Ltd.), an Israeli manufacturer and distributor of crop protection products from 1998 until 2004. Dr. Toledano holds a Ph.D. in chemistry from The Hebrew University of Jerusalem, Israel.

Itai Arkin

Mr. Itai Arkin is Director of the Company. Mr. Itai Arkin currently serves as Investment Manager at Arkin Holdings Ltd. and on the board of directors of Exalenz Bioscience Ltd. Mr. Itai Arkin is an investment committee member of both Accelmed, a leading Israeli MedTech investment firm since March 2014, and of Sphera Global Healthcare, a leading healthcare hedge fund. Mr. Itai Arkin holds a B.A. in business administration (cum laude) from Interdisciplinary Center, Herzliya, Israel.

Jerrold Gattegno

Mr. Jerrold S. Gattegno is Director of the Company. Mr. Gattegno worked in the New York, Washington D.C. and London offices of Deloitte Touche Tohmatsu Limited, a public accounting firm, from 1973 until 2015, where he served in various senior positions, including as the founding partner of Deloitte’s multistate tax practice and as a managing partner in Deloitte’s Washington National Tax Office. Mr. Gattegno has served as a member of the Hispanic Association of Colleges and Universities finance and audit committee from 2012 until 2015. Mr. Gattegno is a certified public accountant and holds a B.S. in accounting (cum laude) from the City University of New York and an M.B.A. in taxation (with honors) from Pace University, New York.

Ran Gottfried

Mr. Ran Gottfried is Director of the Company. Since 1975, Mr. Gottfried has served as a chief executive officer, consultant and director of private companies in Israel and Europe in the areas of retail and distribution of pharmaceuticals, consumer and household products. Mr. Gottfried served as a director of Perrigo Company from 2006 until 2015. From 2006 until 2008, Mr. Gottfried served as chairman and chief executive officer of Powerpaper Ltd., a leading developer and manufacturer of micro electrical cosmetic and pharmaceutical patches. From 2005 until 2010, Mr. Gottfried served as a director of Bezeq, Israel’s leading telecommunications provider and from 2003 until its acquisition by Perrigo Company in 2005, Mr. Gottfried served as a director of Agis Industries Ltd.

Hani Lerman

Ms. Hani Lerman is Director of the Company. Ms. Lerman has served as chief financial officer at Arkin Holdings since 2015. From 2010 until 2014, Ms. Lerman served as chief financial officer of Sansa Security (f/k/a Discretix Technologies), and from 2006 until 2010, she served as chief financial officer of Storwize, which was acquired by IBM in 2010. She serves as a board member of Exalenz Bioscience and Medical Compression Systems. She holds a Master's degree in business administration with a major in finance from Tel-Aviv University, Israel, and a B.A. in economics and accounting from Tel-Aviv University, Israel.

Yael Baratz

Ms. Yael Baratz is an Independent Director of the Company. Ms. Baratz is a Senior Partner and Chair of the Corporate & Licensing Group at the international law firm of Pearl Cohen Zedek Latzer Baratz and works out of its Tel-Aviv office. Ms. Baratz has been in private practice since 1992 and currently serves as the co-chair of the Israel Bar Association’s science and technology committee. Ms. Baratz holds an L.L B. from Tel-Aviv University, Israel.

Shmuel Ben Zvi

Dr. Shmuel Ben Zvi is Independent Director of the Company. Dr. Ben Zvi is currently a board member and member of the audit, risk management and strategy committees at Bank Leumi. From 2004 to 2014, Dr. Ben Zvi held various managerial positions at Teva Pharmaceuticals Industries Ltd., including Vice President of Finance and Vice President of Strategy. From 2000 to 2004, Dr. Ben Zvi was the financial advisor to the Chief of General Staff of the Israel Defense Forces and head of the Defense Ministry budget department. Dr. Ben Zvi holds a Ph.D. in economics from Tel-Aviv University, Israel and participated in the Harvard Business School Advanced Management Program (AMP).